Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Stiewe

Showing results (71-80 of 167) with videos related to

Pageof 17
Sort By:
Plos One|April 23, 2015
Oncogenic NRAS Primes Primary Acute Myeloid Leukemia Cells for DifferentiationCornelia Brendel, Sabine Teichler, Axel Millahn, et al.
Cancers|April 30, 2021
Activation of Cilia-Independent Hedgehog/GLI1 Signaling as a Novel Concept for Neuroblastoma TherapyAnke Koeniger, Anna Brichkina, Iris Nee, et al.
Cell Death Discovery|April 14, 2023
Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysisEva Romanovsky, Klaus Kluck, Iordanis Ourailidis, et al.
Translational Gastroenterology and Hepatology|February 12, 2026
Leptin-dependent fat accumulation triggers autophagy in metabolic dysfunction-associated steatohepatitis modelSophia C H Polte, Tomomitsu Matono, Kinya Okamoto, et al.
Nucleic Acids Research|January 29, 2016
ΔNp63 activates the Fanconi anemia DNA repair pathway and limits the efficacy of cisplatin treatment in squamous cell carcinomaAnne Catherine Bretz, Miriam P Gittler, Joël P Charles, et al.
Cell Communication and Signaling : CCS|November 20, 2024
Arachidonic acid impairs natural killer cell functions by disrupting signaling pathways driven by activating receptors and reactive oxygen speciesMohamad K Hammoud, Celina Meena, Raimund Dietze, et al.
Clinical and Translational Medicine|November 29, 2021
The multicellular signalling network of ovarian cancer metastasesLeah Sommerfeld, Florian Finkernagel, Julia M Jansen, et al.
Cancers|May 3, 2020
YM155-Adapted Cancer Cell Lines Reveal Drug-Induced Heterogeneity and Enable the Identification of Biomarker Candidates for the Acquired Resistance SettingMartin Michaelis, Mark N Wass, Ian Reddin, et al.
Frontiers in Immunology|February 25, 2026
Divergent CD45<sup>+</sup> immune landscapes shape the lung tumor microenvironmentSelma Dizdarević, René Wiegandt, Andreas Weigert, et al.
Cell Death & Disease|October 14, 2016
Effects of YM155 on survivin levels and viability in neuroblastoma cells with acquired drug resistanceYvonne Voges, Martin Michaelis, Florian Rothweiler, et al.
Pageof 17

Showing results (71-80 of 167) with videos related to

Sort By:
Pageof 17
Plos One|April 23, 2015
Oncogenic NRAS Primes Primary Acute Myeloid Leukemia Cells for DifferentiationCornelia Brendel, Sabine Teichler, Axel Millahn, et al.
Cancers|April 30, 2021
Activation of Cilia-Independent Hedgehog/GLI1 Signaling as a Novel Concept for Neuroblastoma TherapyAnke Koeniger, Anna Brichkina, Iris Nee, et al.
Cell Death Discovery|April 14, 2023
Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysisEva Romanovsky, Klaus Kluck, Iordanis Ourailidis, et al.
Translational Gastroenterology and Hepatology|February 12, 2026
Leptin-dependent fat accumulation triggers autophagy in metabolic dysfunction-associated steatohepatitis modelSophia C H Polte, Tomomitsu Matono, Kinya Okamoto, et al.
Nucleic Acids Research|January 29, 2016
ΔNp63 activates the Fanconi anemia DNA repair pathway and limits the efficacy of cisplatin treatment in squamous cell carcinomaAnne Catherine Bretz, Miriam P Gittler, Joël P Charles, et al.
Cell Communication and Signaling : CCS|November 20, 2024
Arachidonic acid impairs natural killer cell functions by disrupting signaling pathways driven by activating receptors and reactive oxygen speciesMohamad K Hammoud, Celina Meena, Raimund Dietze, et al.
Clinical and Translational Medicine|November 29, 2021
The multicellular signalling network of ovarian cancer metastasesLeah Sommerfeld, Florian Finkernagel, Julia M Jansen, et al.
Cancers|May 3, 2020
YM155-Adapted Cancer Cell Lines Reveal Drug-Induced Heterogeneity and Enable the Identification of Biomarker Candidates for the Acquired Resistance SettingMartin Michaelis, Mark N Wass, Ian Reddin, et al.
Frontiers in Immunology|February 25, 2026
Divergent CD45<sup>+</sup> immune landscapes shape the lung tumor microenvironmentSelma Dizdarević, René Wiegandt, Andreas Weigert, et al.
Cell Death & Disease|October 14, 2016
Effects of YM155 on survivin levels and viability in neuroblastoma cells with acquired drug resistanceYvonne Voges, Martin Michaelis, Florian Rothweiler, et al.
Pageof 17